| NCT Number | NCT05842811 |
| Lead Sponsor | Target PharmaSolutions, Inc. |
| Conditions | Metabolic Syndrome |
| Enrollment | 2,000,000 participants |
| Start Date | 2023-05-24 |
| Primary Completion | 2038-12-31 (estimated) |
| Study Completion | 2038-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2023-05-06 |